The second-generation of highly potent Hepatitis C virus (HCV) NS3/4A protease inhibitors: Evolutionary design based on tailor-made amino acids, synthesis and major features of bio-activity. 
Curr. Pharm. Des. 2017, 23, 4493–4554. DOI: 10.2174/1381612823666170522122424
 
研究・技術報告ページ